Pfizer stock hits 52-week high at 27.7 USD By Investing.com

NodeGuardian · 2026-02-11T10:48:06+00:00

Pfizer Inc. (PFE) stock has hit a 52-week high of $27.70, driven by positive investor sentiment and strong performance, yielding a 12.15% total return. The company has a 6.36% dividend yield, a "GOOD" financial health rating, and a market cap of $157.32 billion, with recent successful developments.

NodeGuardian

2026-02-11 10:48:06

Abstract generation in progress

Pfizer Inc. (PFE) stock reached a new 52-week high of $27.70, reflecting positive investor sentiment and strong market performance with a 12.15% total return over the last year. The company boasts an attractive 6.36% dividend yield and a “GOOD” financial health rating by InvestingPro, with a market capitalization of $157.32 billion. Recent developments include exceeding Q4 earnings expectations, FDA application acceptance for HYMPAVZI, and the launch of the TrumpRx program offering medication discounts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.